Medical Weight Loss for Havre, Montana Residents
Havre, Montana residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Havre through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Havre Residents Choose New Hope Weight Loss
Havre patients choose New Hope Weight Loss because a named physician, Dr. Anjmun Sharma, M.D., oversees every case, pricing is transparent (semaglutide from $166/month, tirzepatide from $233/month · just $7.70/day), and the entire program runs by telehealth from our Costa Mesa, California clinic, which has served over 5,400 patients across Montana and beyond since 2020.
Havre patients are cared for entirely through telehealth from our Costa Mesa, California clinic. There is no travel, your consultation with Dr. Sharma, prescription, and follow-ups all happen by secure video.
For Havre, medical weight loss is delivered online from our Costa Mesa, California practice, with no travel required. We care for patients throughout downtown Havre and the Hi-Line of north-central Montana. Every prescription for Havre is authorized by Dr. Sharma after reviewing your history, and follow-up continues by video throughout the program.
Telehealth removes the distance between Havre and specialized care: your consultation happens wherever you are in Montana. We accept HSA, FSA, Klarna, and Affirm, with no mandatory membership and no surprise charges for Havre patients.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Havre
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Havre
First, you complete the online medical intake in a few minutes. Next, Dr. Sharma reviews your history by secure video, usually within 48 hours. If you are a candidate and telehealth-eligible, your compounded medication ships to your Havre address in cold-pack packaging, and follow-ups and dose adjustments continue by video, with no travel.
Frequently Asked Questions, Havre
Does New Hope Weight Loss treat patients in Havre?
Yes. Although the clinic is in Costa Mesa, California, we treat Havre, Montana residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Havre?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Havre address in cold-pack packaging.
What do Havre patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Havre do you serve?
We serve patients from across Havre by telehealth, including downtown Havre and the Hi-Line of north-central Montana.
How is medication shipped to Havre patients?
After Dr. Sharma approves your plan, compounded medication ships in discreet, temperature-appropriate packaging directly to your Havre address from the identified 503(a) compounding pharmacy. Most patients receive it within days, with no pharmacy line and no drive.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Havre, Montana by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.